글로벌 현기증 치료 시장 – 2028년까지의 산업 동향 및 예측

현기증 치료 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 현기증 치료가 2021-2028년 예측 기간 동안 약 4.70%의 CAGR을 보일 것이라고 분석했습니다. 표적 치료 모드에 대한 수요 증가, 신약 및 치료법 개발을 위한 연구 개발 활동 급증, 충족되지 않은 높은 치료 요구 및 의료 인프라 개발에 대한 지출 증가 는 현기증 치료 시장 성장에 기인하는 주요 요인입니다.

이름 자체에서 알 수 있듯이 현기증은 사람이 주변의 모든 물체가 움직이지 않는데도 움직이는 것처럼 느끼는 의학적 상태입니다. 현기증은 현기증의 흔한 형태이며 종종 보행 장애, 발한, 메스꺼움과 관련이 있습니다. 균형 장애라고도 합니다. 

전 세계적으로 현기증의 유병률이 증가하는 것은 시장 성장을 촉진하는 주요 요인입니다. 의료 인프라 개발에 대한 지출 증가, 과산소뇨증과 관련된 위험을 치료하는 데 사용되는 약물의 부상 증가, 규제 당국의 특별 지정 급증은 시장 성장을 촉진하는 다른 요인입니다. 개인의 가처분 소득 증가와 스포츠 관련 부상의 유병률 증가는 수익성 있는 시장 성장 기회를 창출할 또 다른 간접적인 결정 요인입니다.

그러나 제네릭 약물의 도입 증가는 시장 성장에 큰 도전이 될 것입니다. 또한, 연구 개발 능력과 관련된 높은 비용과 숙련된 전문가의 부족이 시장 성장률을 더욱 떨어뜨릴 것입니다. 브랜드 약물의 특허 만료도 시장 성장률을 방해할 것입니다.

This vertigo treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on vertigo treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Vertigo Treatment Market Scope and Market Size

The vertigo treatment market is segmented on the basis of type, treatment type, drugs, route of administration and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the vertigo treatment market is segmented into peripheral vertigo and central vertigo.
• On the basis of treatment type, the vertigo treatment market is segmented into medication and surgery. Medication segment is sub-segmented into over-the-counter drugs and prescription drugs. Surgery segment is sub-segmented into canal plugging surgery.
• On the basis of drugs, the vertigo treatment market is segmented into corticosteroids, antibiotics, vestibular suppressants and others. Corticosteroids segment is sub-segmented into methylprednisolone. Antibiotics segment is sub-segmented into amoxicillin. Vestibular suppressants segment is sub-segmented into meclizine.
• On the basis of route of administration, the vertigo treatment market is segmented into oral and injectable.  
• On the basis of end users, the vertigo treatment market is segmented into hospitals, home care, speciality clinics and others.

Vertigo Treatment Market Country Level Analysis

The vertigo treatment market is segmented on the basis of type, treatment type, drugs, route of administration and end users.

The countries covered in the vertigo treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the vertigo treatment market owing to the rising affordability of drugs and surge in the cases of vertigo. Asia-Pacific is projected to score highest growth rate and exhibit the highest CAGR for the forecast period. This is because of the rising expenditure to develop healthcare infrastructure and ever-rising geriatric population.

The country section of the vertigo treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The vertigo treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Vertigo Treatment Market Share Analysis

The vertigo treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to vertigo treatment market.

The major players covered in the vertigo treatment market report are Mylan N.V., Amneal Pharmaceuticals LLC, Epic Pharma, LLC, Endo Pharmaceuticals Inc., Novartis AG, Jubilant Life Sciences Ltd, Pfizer Inc., Vintage Labs, Teva Pharmaceutical Industries Ltd, Zydus Cadila, Lupin., Sagent Pharmaceuticals, Inc., Altamira Therapeutics, Sensorion, Casper Pharma, Indicus Pharma, F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Eli Lilly and Company and Sun Pharmaceutical Industries Ltd. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-48000